Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Enterprise Value (2018 - 2025)

Viemed Healthcare's Enterprise Value history spans 8 years, with the latest figure at -$11.5 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 26.27% year-over-year to -$11.5 million; the TTM value through Dec 2025 reached -$11.5 million, up 26.27%, while the annual FY2025 figure was -$11.5 million, 26.27% up from the prior year.
  • Enterprise Value reached -$11.5 million in Q4 2025 per VMD's latest filing, down from -$9.2 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$7.0 million in Q2 2024 to a low of -$31.2 million in Q2 2021.
  • Average Enterprise Value over 5 years is -$17.5 million, with a median of -$16.3 million recorded in 2022.
  • Peak YoY movement for Enterprise Value: tumbled 269.81% in 2021, then soared 68.96% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$28.4 million in 2021, then skyrocketed by 40.46% to -$16.9 million in 2022, then increased by 24.09% to -$12.8 million in 2023, then fell by 21.75% to -$15.6 million in 2024, then increased by 26.27% to -$11.5 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Enterprise Value are -$11.5 million (Q4 2025), -$9.2 million (Q3 2025), and -$18.1 million (Q2 2025).